Patients with early rheumatoid arthritis who began treatment within the first 12 weeks of symptom onset were two times more likely to achieve remission than those who started treatment later, a study involving 1,795 patients found. The odds of achieving remission were 1.65 times higher in patients treated with disease-modifying antirheumatic drugs within the first three months of onset compared with those who started DMARD therapy later. The study was published in Annals of the Rheumatic Diseases.

Full Story:

Related Summaries